| Dichotomous health status groups | N | Utility value (Mean [SD]) | t-test | REa | ROC curve | ||
---|---|---|---|---|---|---|---|---|
t-statistic | p Value | AUC | 95% CI | |||||
EQ-5D-5L | Hypertension | 6806 | 0.894 (0.216) |  − 27.812 |  < 0.001 | 1.000 | 0.626* | (0.619, 0.633) |
Non-hypertension | 12,371 | 0.963 (0.128) | Â | Â | Â | Â | Â | |
SF-6Dv2 | Hypertension | 6806 | 0.803 (0.216) |  − 39.772 |  < 0.001 | 2.045 | 0.699* | (0.692, 0.707) |
Non-hypertension | 12,371 | 0.909 (0.151) | Â | Â | Â | Â | Â | |
EQ-5D-5L | Diabetes | 2586 | 0.885 (0.224) |  − 17.736 |  < 0.001 | 1.000 | 0.610* | (0.599, 0.620) |
Non-diabetes | 16,591 | 0.947 (0.156) | Â | Â | Â | Â | Â | |
SF-6Dv2 | Diabetes | 2586 | 0.793 (0.220) |  − 23.735 |  < 0.001 | 1.791 | 0.663* | (0.652, 0.674) |
Non-diabetes | 16,591 | 0.884 (0.175) | Â | Â | Â | Â | Â | |
EQ-5D-5L | Other chronic diseases | 1082 | 0.810 (0.289) |  − 26.512 |  < 0.001 | 1.000 | 0.702* | (0.686, 0.718) |
Non-other chronic diseases | 18,095 | 0.947 (0.154) | Â | Â | Â | Â | Â | |
SF-6Dv2 | Other chronic diseases | 1082 | 0.695 (0.292) |  − 33.439 |  < 0.001 | 1.591 | 0.730* | (0.714, 0.746) |
Non-other chronic diseases | 18,095 | 0.882 (0.170) | Â | Â | Â | Â | Â | |
EQ-5D-5L | Illnesses in 2 weeks | 1654 | 0.882 (0.230) |  − 14.448 |  < 0.001 | 1.000 | 0.605* | (0.592, 0.618) |
Non-illnesses in 2Â weeks | 17,523 | 0.944 (0.160) | Â | Â | Â | Â | Â | |
SF-6Dv2 | Illnesses in 2 weeks | 1654 | 0.769 (0.245) |  − 24.141 |  < 0.001 | 2.792 | 0.676* | (0.663, 0.689) |
Non-illnesses in 2Â weeks | 17,523 | 0.882 (0.174) | Â | Â | Â | Â | Â | |
EQ-5D-5L | Hospitalizations in 12 months | 733 | 0.803 (0.304) |  − 22.606 |  < 0.001 | 1.000 | 0.683* | (0.663, 0.703) |
Non-hospitalizations in 12Â months | 18,444 | 0.944 (0.158) | Â | Â | Â | Â | Â | |
SF-6Dv2 | Hospitalizations in 12 months | 733 | 0.703 (0.288) |  − 25.679 |  < 0.001 | 1.290 | 0.719* | (0.699, 0.738) |
Non-hospitalizations in 12Â months | 18,444 | 0.878 (0.176) | Â | Â | Â | Â | Â |